MTA2_HUMAN - dbPTM
MTA2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MTA2_HUMAN
UniProt AC O94776
Protein Name Metastasis-associated protein MTA2
Gene Name MTA2
Organism Homo sapiens (Human).
Sequence Length 668
Subcellular Localization Nucleus .
Protein Description May be involved in the regulation of gene expression as repressor and activator. The repression might be related to covalent modification of histone proteins..
Protein Sequence MAANMYRVGDYVYFENSSSNPYLVRRIEELNKTANGNVEAKVVCLFRRRDISSSLNSLADSNAREFEEESKQPGVSEQQRHQLKHRELFLSRQFESLPATHIRGKCSVTLLNETDILSQYLEKEDCFFYSLVFDPVQKTLLADQGEIRVGCKYQAEIPDRLVEGESDNRNQQKMEMKVWDPDNPLTDRQIDQFLVVARAVGTFARALDCSSSIRQPSLHMSAAAASRDITLFHAMDTLQRNGYDLAKAMSTLVPQGGPVLCRDEMEEWSASEAMLFEEALEKYGKDFNDIRQDFLPWKSLASIVQFYYMWKTTDRYIQQKRLKAAEADSKLKQVYIPTYTKPNPNQIISVGSKPGMNGAGFQKGLTCESCHTTQSAQWYAWGPPNMQCRLCASCWIYWKKYGGLKTPTQLEGATRGTTEPHSRGHLSRPEAQSLSPYTTSANRAKLLAKNRQTFLLQTTKLTRLARRMCRDLLQPRRAARRPYAPINANAIKAECSIRLPKAAKTPLKIHPLVRLPLATIVKDLVAQAPLKPKTPRGTKTPINRNQLSQNRGLGGIMVKRAYETMAGAGVPFSANGRPLASGIRSSSQPAAKRQKLNPADAPNPVVFVATKDTRALRKALTHLEMRRAARRPNLPLKVKPTLIAVRPPVPLPAPSHPASTNEPIVLED
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MAANMYRVGDYVY
--CCCCCEEECCEEE
11.2724043423
11PhosphorylationNMYRVGDYVYFENSS
CCEEECCEEEEECCC
7.3622817900
13PhosphorylationYRVGDYVYFENSSSN
EEECCEEEEECCCCC
10.0324719451
17PhosphorylationDYVYFENSSSNPYLV
CEEEEECCCCCHHHH
28.1324043423
18PhosphorylationYVYFENSSSNPYLVR
EEEEECCCCCHHHHH
45.7924043423
19PhosphorylationVYFENSSSNPYLVRR
EEEECCCCCHHHHHH
41.4624719451
22PhosphorylationENSSSNPYLVRRIEE
ECCCCCHHHHHHHHH
23.2917360941
32AcetylationRRIEELNKTANGNVE
HHHHHHHHHCCCCEE
62.7325953088
32UbiquitinationRRIEELNKTANGNVE
HHHHHHHHHCCCCEE
62.7321890473
41AcetylationANGNVEAKVVCLFRR
CCCCEEEEEEEEEEC
22.9926051181
41UbiquitinationANGNVEAKVVCLFRR
CCCCEEEEEEEEEEC
22.99-
52PhosphorylationLFRRRDISSSLNSLA
EEECCCCHHHHHHHH
20.4027794612
53PhosphorylationFRRRDISSSLNSLAD
EECCCCHHHHHHHHH
38.9030266825
54PhosphorylationRRRDISSSLNSLADS
ECCCCHHHHHHHHHH
25.4430266825
57PhosphorylationDISSSLNSLADSNAR
CCHHHHHHHHHHCHH
30.1730266825
61PhosphorylationSLNSLADSNAREFEE
HHHHHHHHCHHHHHH
27.1221406692
70PhosphorylationAREFEEESKQPGVSE
HHHHHHHHCCCCCCH
39.6121815630
71AcetylationREFEEESKQPGVSEQ
HHHHHHHCCCCCCHH
64.8926051181
71UbiquitinationREFEEESKQPGVSEQ
HHHHHHHCCCCCCHH
64.8921890473
105AcetylationPATHIRGKCSVTLLN
CCCEECCCCEEEEEC
17.3126051181
152AcetylationGEIRVGCKYQAEIPD
CCEEECEEEEEECCC
34.1719608861
152MalonylationGEIRVGCKYQAEIPD
CCEEECEEEEEECCC
34.1726320211
152UbiquitinationGEIRVGCKYQAEIPD
CCEEECEEEEEECCC
34.1719608861
160MethylationYQAEIPDRLVEGESD
EEEECCCCCCCCCCC
34.97115483943
169MethylationVEGESDNRNQQKMEM
CCCCCCCHHHHCEEE
47.53115483951
173AcetylationSDNRNQQKMEMKVWD
CCCHHHHCEEEEECC
27.3625953088
173MethylationSDNRNQQKMEMKVWD
CCCHHHHCEEEEECC
27.36115483959
173UbiquitinationSDNRNQQKMEMKVWD
CCCHHHHCEEEEECC
27.36-
177UbiquitinationNQQKMEMKVWDPDNP
HHHCEEEEECCCCCC
27.20-
188MethylationPDNPLTDRQIDQFLV
CCCCCCHHHHHHHHH
30.07115483935
217PhosphorylationSSSIRQPSLHMSAAA
CCCCCCCCHHHHHHH
23.6721406692
221PhosphorylationRQPSLHMSAAAASRD
CCCCHHHHHHHHHCC
12.1921406692
226PhosphorylationHMSAAAASRDITLFH
HHHHHHHHCCHHHHH
26.2621406692
237PhosphorylationTLFHAMDTLQRNGYD
HHHHHHHHHHHCCHH
16.2324945436
282UbiquitinationLFEEALEKYGKDFND
HHHHHHHHHCCCHHH
61.22-
285UbiquitinationEALEKYGKDFNDIRQ
HHHHHHCCCHHHHHH
56.93-
320UbiquitinationTDRYIQQKRLKAAEA
HHHHHHHHHHHHHHH
43.24-
332AcetylationAEADSKLKQVYIPTY
HHHCHHCCEEECCCC
41.2620167786
335PhosphorylationDSKLKQVYIPTYTKP
CHHCCEEECCCCCCC
9.93-
339PhosphorylationKQVYIPTYTKPNPNQ
CEEECCCCCCCCCCC
13.86-
341AcetylationVYIPTYTKPNPNQII
EECCCCCCCCCCCEE
32.1720167786
341UbiquitinationVYIPTYTKPNPNQII
EECCCCCCCCCCCEE
32.17-
352PhosphorylationNQIISVGSKPGMNGA
CCEEEECCCCCCCCC
33.2625159151
353AcetylationQIISVGSKPGMNGAG
CEEEECCCCCCCCCC
39.3925953088
393PhosphorylationMQCRLCASCWIYWKK
HHCCHHHHHHHHHHH
14.6920860994
397PhosphorylationLCASCWIYWKKYGGL
HHHHHHHHHHHCCCC
6.1520860994
399AcetylationASCWIYWKKYGGLKT
HHHHHHHHHCCCCCC
21.1026051181
401PhosphorylationCWIYWKKYGGLKTPT
HHHHHHHCCCCCCCC
16.8223186163
405UbiquitinationWKKYGGLKTPTQLEG
HHHCCCCCCCCCCCC
56.59-
406PhosphorylationKKYGGLKTPTQLEGA
HHCCCCCCCCCCCCC
36.2925159151
408PhosphorylationYGGLKTPTQLEGATR
CCCCCCCCCCCCCCC
51.5223186163
414PhosphorylationPTQLEGATRGTTEPH
CCCCCCCCCCCCCCC
40.2523186163
427PhosphorylationPHSRGHLSRPEAQSL
CCCCCCCCCHHHHCC
39.8625159151
433PhosphorylationLSRPEAQSLSPYTTS
CCCHHHHCCCCCCCC
37.5525159151
435PhosphorylationRPEAQSLSPYTTSAN
CHHHHCCCCCCCCHH
22.5520201521
437PhosphorylationEAQSLSPYTTSANRA
HHHCCCCCCCCHHHH
21.1930266825
438PhosphorylationAQSLSPYTTSANRAK
HHCCCCCCCCHHHHH
20.0530266825
439PhosphorylationQSLSPYTTSANRAKL
HCCCCCCCCHHHHHH
21.7230266825
440PhosphorylationSLSPYTTSANRAKLL
CCCCCCCCHHHHHHH
18.7530266825
453PhosphorylationLLAKNRQTFLLQTTK
HHHHCCCHHHHHHHH
17.0228555341
458PhosphorylationRQTFLLQTTKLTRLA
CCHHHHHHHHHHHHH
26.35-
459PhosphorylationQTFLLQTTKLTRLAR
CHHHHHHHHHHHHHH
15.87-
460AcetylationTFLLQTTKLTRLARR
HHHHHHHHHHHHHHH
51.77-
460UbiquitinationTFLLQTTKLTRLARR
HHHHHHHHHHHHHHH
51.7721890473
460UbiquitinationTFLLQTTKLTRLARR
HHHHHHHHHHHHHHH
51.7721890473
483PhosphorylationRRAARRPYAPINANA
HHHHCCCCCCCCHHH
24.1728152594
492AcetylationPINANAIKAECSIRL
CCCHHHEEEEEEEEC
35.4025953088
496PhosphorylationNAIKAECSIRLPKAA
HHEEEEEEEECCCCC
11.4025159151
504UbiquitinationIRLPKAAKTPLKIHP
EECCCCCCCCCCCCC
56.38-
505PhosphorylationRLPKAAKTPLKIHPL
ECCCCCCCCCCCCCC
29.1823927012
508AcetylationKAAKTPLKIHPLVRL
CCCCCCCCCCCCCCC
39.9226051181
508SumoylationKAAKTPLKIHPLVRL
CCCCCCCCCCCCCCC
39.9228112733
508UbiquitinationKAAKTPLKIHPLVRL
CCCCCCCCCCCCCCC
39.9221890473
508UbiquitinationKAAKTPLKIHPLVRL
CCCCCCCCCCCCCCC
39.9221890473
519PhosphorylationLVRLPLATIVKDLVA
CCCCCHHHHHHHHHH
33.7020068231
522AcetylationLPLATIVKDLVAQAP
CCHHHHHHHHHHCCC
41.30-
522UbiquitinationLPLATIVKDLVAQAP
CCHHHHHHHHHHCCC
41.3021890473
522UbiquitinationLPLATIVKDLVAQAP
CCHHHHHHHHHHCCC
41.3021890473
531AcetylationLVAQAPLKPKTPRGT
HHHCCCCCCCCCCCC
43.3323954790
531UbiquitinationLVAQAPLKPKTPRGT
HHHCCCCCCCCCCCC
43.33-
534PhosphorylationQAPLKPKTPRGTKTP
CCCCCCCCCCCCCCC
27.0925159151
538PhosphorylationKPKTPRGTKTPINRN
CCCCCCCCCCCCCHH
32.7830576142
539UbiquitinationPKTPRGTKTPINRNQ
CCCCCCCCCCCCHHH
55.94-
540PhosphorylationKTPRGTKTPINRNQL
CCCCCCCCCCCHHHH
29.2820068231
548PhosphorylationPINRNQLSQNRGLGG
CCCHHHHHCCCCCCH
18.6925159151
551MethylationRNQLSQNRGLGGIMV
HHHHHCCCCCCHHHH
33.79115483927
559AcetylationGLGGIMVKRAYETMA
CCCHHHHHHHHHHHC
17.5825953088
559MethylationGLGGIMVKRAYETMA
CCCHHHHHHHHHHHC
17.587614655
559SumoylationGLGGIMVKRAYETMA
CCCHHHHHHHHHHHC
17.5828112733
559UbiquitinationGLGGIMVKRAYETMA
CCCHHHHHHHHHHHC
17.58-
562PhosphorylationGIMVKRAYETMAGAG
HHHHHHHHHHHCCCC
18.90-
564PhosphorylationMVKRAYETMAGAGVP
HHHHHHHHHCCCCCC
10.3120068231
573PhosphorylationAGAGVPFSANGRPLA
CCCCCCCCCCCCCCC
18.1129978859
581PhosphorylationANGRPLASGIRSSSQ
CCCCCCCCCCCCCCC
42.3020068231
586PhosphorylationLASGIRSSSQPAAKR
CCCCCCCCCCHHHHH
24.1228555341
587PhosphorylationASGIRSSSQPAAKRQ
CCCCCCCCCHHHHHH
41.2426853621
592AcetylationSSSQPAAKRQKLNPA
CCCCHHHHHHCCCCC
58.4230585581
595AcetylationQPAAKRQKLNPADAP
CHHHHHHCCCCCCCC
55.0225953088
595SumoylationQPAAKRQKLNPADAP
CHHHHHHCCCCCCCC
55.0228112733
610PhosphorylationNPVVFVATKDTRALR
CCEEEEEECCHHHHH
24.9322210691
611AcetylationPVVFVATKDTRALRK
CEEEEEECCHHHHHH
47.5725953088
611UbiquitinationPVVFVATKDTRALRK
CEEEEEECCHHHHHH
47.5721890473
611UbiquitinationPVVFVATKDTRALRK
CEEEEEECCHHHHHH
47.5721890473
621PhosphorylationRALRKALTHLEMRRA
HHHHHHHHHHHHHHH
29.31-
655PhosphorylationPVPLPAPSHPASTNE
CCCCCCCCCCCCCCC
44.1828555341
659PhosphorylationPAPSHPASTNEPIVL
CCCCCCCCCCCCCCC
35.9027251275
660PhosphorylationAPSHPASTNEPIVLE
CCCCCCCCCCCCCCC
45.7927251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MTA2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MTA2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MTA2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CHD4_HUMANCHD4physical
12920132
SIN3A_HUMANSIN3Aphysical
12920132
MTA1_HUMANMTA1physical
12920132
HDAC1_HUMANHDAC1physical
12920132
HDAC2_HUMANHDAC2physical
12920132
RBBP4_HUMANRBBP4physical
12920132
RBBP7_HUMANRBBP7physical
12920132
TOP2B_HUMANTOP2Bphysical
11062478
HDAC1_HUMANHDAC1physical
10444591
HDAC2_HUMANHDAC2physical
10444591
RBBP4_HUMANRBBP4physical
10444591
RBBP7_HUMANRBBP7physical
10444591
MBD3_HUMANMBD3physical
10444591
CHD3_HUMANCHD3physical
10444591
HDAC1_HUMANHDAC1physical
19686092
HDAC2_HUMANHDAC2physical
19686092
RBBP4_HUMANRBBP4physical
19686092
MED30_HUMANMED30physical
20211142
ESR1_HUMANESR1physical
16645043
HDAC1_HUMANHDAC1physical
16645043
BC11B_HUMANBCL11Bphysical
16091750
CHD3_HUMANCHD3physical
11297506
HDAC1_HUMANHDAC1physical
11297506
HDAC2_HUMANHDAC2physical
11297506
RBBP7_HUMANRBBP7physical
11297506
RBBP4_HUMANRBBP4physical
11297506
MBD2_HUMANMBD2physical
11297506
MBD3_HUMANMBD3physical
11297506
HDAC1_HUMANHDAC1physical
11102443
HDAC2_HUMANHDAC2physical
11102443
MBD2_HUMANMBD2physical
11102443
TRX1_HHV11UL38physical
20585571
BRCA1_HUMANBRCA1physical
19703393
CHD3_HUMANCHD3physical
19703393
CHD4_HUMANCHD4physical
19703393
KDM1A_HUMANKDM1Aphysical
19703393
HDAC1_HUMANHDAC1physical
19703393
HDAC2_HUMANHDAC2physical
19703393
RBBP7_HUMANRBBP7physical
19703393
RBBP4_HUMANRBBP4physical
19703393
MBD3_HUMANMBD3physical
19703393
RBBP7_HUMANRBBP7physical
20714342
HDAC2_HUMANHDAC2physical
20714342
TWST1_HUMANTWIST1physical
22457607
RBBP4_HUMANRBBP4physical
22939629
RBBP7_HUMANRBBP7physical
22939629
P66B_HUMANGATAD2Bphysical
22939629
P66A_HUMANGATAD2Aphysical
22939629
T22D3_HUMANTSC22D3physical
21988832
UBE3C_HUMANUBE3Cphysical
21988832
BRCC3_HUMANBRCC3physical
22863883
CD2AP_HUMANCD2APphysical
22863883
EH1L1_HUMANEHBP1L1physical
22863883
GEPH_HUMANGPHNphysical
22863883
JIP4_HUMANSPAG9physical
22863883
LARP7_HUMANLARP7physical
22863883
MAP4_HUMANMAP4physical
22863883
LSM8_HUMANLSM8physical
22863883
RPB1_HUMANPOLR2Aphysical
22863883
RPB3_HUMANPOLR2Cphysical
22863883
PP4R1_HUMANPPP4R1physical
22863883
RABE2_HUMANRABEP2physical
22863883
ROCK2_HUMANROCK2physical
22863883
NACC2_HUMANNACC2physical
22926524
DNMT1_HUMANDNMT1physical
23708667
P66A_HUMANGATAD2Aphysical
26344197
MTA1_HUMANMTA1physical
26344197
RBBP4_HUMANRBBP4physical
28179136
RBBP7_HUMANRBBP7physical
28179136
IMA1_HUMANKPNA2physical
28179136
IMB1_HUMANKPNB1physical
28179136
ZN827_HUMANZNF827physical
25150861

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MTA2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-152, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; SER-435; THR-505AND THR-534, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-540, AND MASSSPECTROMETRY.

TOP